{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:34:49Z","timestamp":1792928089751,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jad.2026.121310","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:05:12Z","timestamp":1769792712000},"page":"121310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The effect of glucagon-like peptide 1 (GLP-1) receptor agonists on cognition: A systematic review of systematic reviews and meta-analyses"],"prefix":"10.1016","volume":"402","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4064-5588","authenticated-orcid":false,"given":"Hana","family":"Ballum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0123-2016","authenticated-orcid":false,"given":"Christine","family":"Dri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4843-0942","authenticated-orcid":false,"given":"Sonya","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5244-8487","authenticated-orcid":false,"given":"Minyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6457-0086","authenticated-orcid":false,"given":"Gia Han","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0928-3433","authenticated-orcid":false,"given":"Sabrina","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8429-6563","authenticated-orcid":false,"given":"Kayla M.","family":"Teopiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4013-1112","authenticated-orcid":false,"given":"Angela T.H.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9629-4493","authenticated-orcid":false,"given":"Roger","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8404-8006","authenticated-orcid":false,"given":"Hayun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4773-2191","authenticated-orcid":false,"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5982-1335","authenticated-orcid":false,"given":"Maj","family":"Vinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2551-5230","authenticated-orcid":false,"given":"Heidi","family":"K.Y.Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-2523","authenticated-orcid":false,"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jad.2026.121310_bb0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/diabetology3010003","article-title":"Type 2 diabetes and impaired physical function: a growing problem","volume":"3","author":"Ahmad","year":"2022","journal-title":"Diabetology"},{"issue":"4","key":"10.1016\/j.jad.2026.121310_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47040285","article-title":"The expanding role of GLP-1 receptor agonists: advancing clinical outcomes in metabolic and mental health","volume":"47","author":"Al Qassab","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"4","key":"10.1016\/j.jad.2026.121310_bb0015","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/1570159X19666210517114016","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: opportunities for drug development","volume":"20","author":"Bhatia","year":"2022","journal-title":"Curr. Neuropharmacol."},{"issue":"11","key":"10.1016\/j.jad.2026.121310_bb0020","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.17219\/acem\/161734","article-title":"Evaluating the effects of glucagon-like peptide-1 receptor agonists on cognitive function in Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"32","author":"Bi","year":"2023","journal-title":"Adv. Clin. Exp. Med."},{"issue":"7","key":"10.1016\/j.jad.2026.121310_bb0025","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/jdi.14015","article-title":"Cognitive protection of incretin-based therapies in patients with type 2 diabetes mellitus: a systematic review and meta-analysis based on clinical studies","volume":"14","author":"Chai","year":"2023","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.jad.2026.121310_bb0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tins.2022.03.001","article-title":"Insulin action in the brain: cell types, circuits, and diseases","volume":"45","author":"Chen","year":"2022","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jad.2026.121310_bb0035","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1445-5994.2012.02758.x","article-title":"Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies","volume":"42","author":"Cheng","year":"2012","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.jad.2026.121310_bb0040","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2147\/DDDT.S348055","article-title":"The role of glucagon-like peptide-1 receptor agonists (GLP-1 RA) in diabetes-related neurodegenerative diseases","volume":"16","author":"Cheng","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"issue":"7","key":"10.1016\/j.jad.2026.121310_bb0045","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","article-title":"Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial","volume":"19","author":"Cukierman-Yaffe","year":"2020","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jad.2026.121310_bb0050","article-title":"Evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer\u2019s disease","volume":"17","author":"Cummings","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"1","key":"10.1016\/j.jad.2026.121310_bb0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MED.0000000000000783","article-title":"Type 2 diabetes mellitus and cognitive function: Understanding the connections","volume":"30","author":"Dao","year":"2023","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"13","key":"10.1016\/j.jad.2026.121310_bb0060","article-title":"The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer\u2019s disease","volume":"17","author":"Du","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.jad.2026.121310_bb0065","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00401-017-1694-x","article-title":"IRE1 signaling exacerbates Alzheimer's disease pathogenesis","volume":"134","author":"Duran-Aniotz","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"10193","key":"10.1016\/j.jad.2026.121310_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jad.2026.121310_bb4000","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2215-0366(16)30067-0","article-title":"Selection of cognitive tests for trials of therapeutic agents","volume":"3","author":"Harrison","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2026.121310_bb0075","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/13872877251319054","article-title":"Effect of diabetes medications on the risk of developing dementia, mild cognitive impairment, or cognitive decline: a systematic review and meta-analysis","volume":"104","author":"Hui","year":"2025","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"10","key":"10.1016\/j.jad.2026.121310_bb0080","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00592-020-01529-1","article-title":"The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"57","author":"Jin","year":"2020","journal-title":"Acta Diabetol."},{"issue":"4","key":"10.1016\/j.jad.2026.121310_bb0085","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/er.2007-0034","article-title":"Cognitive dysfunction and diabetes mellitus","volume":"29","author":"Kodl","year":"2008","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.jad.2026.121310_bb0090","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/dom.15331","article-title":"Diabetes, antidiabetic medications and risk of dementia: a systematic umbrella review and meta-analysis","volume":"26","author":"Kuate Defo","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jad.2026.121310_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1047883","article-title":"Impact of glucagon-like peptide 1 analogs on cognitive function among patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"13","author":"Luan","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"7","key":"10.1016\/j.jad.2026.121310_bb0100","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jamainternmed.2025.1189","article-title":"Glucose-lowering medications, glycemia, and cognitive outcomes: the GRADE randomized clinical trial","volume":"185","author":"Luchsinger","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jad.2026.121310_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01269-y","article-title":"Late-life depression and increased risk of dementia: a longitudinal cohort study","volume":"11","author":"Ly","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2026.121310_bb0110","article-title":"Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?","volume":"7","author":"Ma","year":"2020","journal-title":"Mil. Med. Res."},{"issue":"2","key":"10.1016\/j.jad.2026.121310_bb0115","article-title":"Cognitive impairment in type 2 diabetes mellitus","volume":"14","author":"Malik","year":"2022","journal-title":"Cureus"},{"issue":"Pt B","key":"10.1016\/j.jad.2026.121310_bb3000","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neuropharm.2018.01.048","article-title":"Cognitive dysfunction and metabolic comorbidities in mood disorders: a repurposing opportunity for glucagon-like peptide 1 receptor agonists?","volume":"136","author":"Mansur","year":"2018","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.jad.2026.121310_bb0120","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/070674371405901203","article-title":"Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors","volume":"59","author":"Maxwell","year":"2014","journal-title":"Can. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.jad.2026.121310_bb0125","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.24com15322","article-title":"The co-occurrence of depression and obesity: implications for clinical practice and the discovery of targeted and precise mechanistically informed therapeutics","volume":"85","author":"McIntyre","year":"2024","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2026.121310_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101470","article-title":"GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes","volume":"49","author":"Monney","year":"2023","journal-title":"Diabetes Metab."},{"issue":"18","key":"10.1016\/j.jad.2026.121310_bb0135","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1212\/WNL.0000000000004586","article-title":"Metformin vs sulfonylurea use and risk of dementia in US veterans aged \u226565 years with diabetes","volume":"89","author":"Orkaby","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2026.121310_bb0140","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.jad.2026.121310_bb0145","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2337\/dc20-0892","article-title":"Metformin use is associated with slowed cognitive decline and reduced incident dementia in older adults with type 2 diabetes: the Sydney Memory and Ageing Study","volume":"43","author":"Samaras","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jad.2026.121310_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-025-02962-8","article-title":"Neurodegeneration onset with glucagon-like peptide-1 receptor agonists in people with type 2 diabetes: a real-world multinational cohort study","volume":"24","author":"Schechter","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.jad.2026.121310_bb5000","article-title":"Baseline characteristics from evoke and evoke+: two phase 3 randomized placebo-controlled trials of semaglutide in participants with early-stage symptomatic Alzheimer's disease","volume":"12","author":"Scheltens","year":"2026","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"10.1016\/j.jad.2026.121310_bb0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4239\/wjd.v14.i2.92","article-title":"Diabetes and cognitive function: an evidence-based current perspective","volume":"14","author":"Sebastian","year":"2023","journal-title":"World J. Diabetes"},{"issue":"7","key":"10.1016\/j.jad.2026.121310_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3673","article-title":"Comparison on cognitive outcomes of antidiabetic agents for type 2 diabetes: a systematic review and network meta-analysis","volume":"39","author":"Tian","year":"2023","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"4","key":"10.1016\/j.jad.2026.121310_bb0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4239\/wjd.v8.i4.120","article-title":"Type 2 diabetes and quality of life","volume":"8","author":"Trikkalinou","year":"2017","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.jad.2026.121310_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1018027","article-title":"Efficacy and safety of hypoglycemic drugs in improving cognitive function in patients with Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and network meta-analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.jad.2026.121310_bb0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1134\/S1819712423020204","article-title":"Glucagon-like peptide 1 receptor agonists in Alzheimer\u2019s disease","volume":"17","author":"Wang","year":"2023","journal-title":"Neurochem. J."},{"issue":"4","key":"10.1016\/j.jad.2026.121310_bb2000","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s40120-025-00724-y","article-title":"Are Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review","volume":"14","author":"West","year":"2025","journal-title":"Neurol Ther."},{"issue":"5","key":"10.1016\/j.jad.2026.121310_bb0180","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/EJE-19-0259","article-title":"Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case-control study","volume":"181","author":"Wium-Andersen","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jad.2026.121310_bb0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diabres.2016.10.024","article-title":"An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer\u2019s disease","volume":"124","author":"Zhang","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jad.2026.121310_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101180","article-title":"GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease","volume":"47","author":"Zheng","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jad.2026.121310_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154265","article-title":"Impact of antidiabetic agents on dementia risk: a Bayesian network meta-analysis","volume":"109","author":"Zhou","year":"2020","journal-title":"Metabolism"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726001618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726001618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:09:22Z","timestamp":1782274162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726001618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"alternative-id":["S0165032726001618"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121310","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of glucagon-like peptide 1 (GLP-1) receptor agonists on cognition: A systematic review of systematic reviews and meta-analyses","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121310"}}